The multifaceted nature of Tourette syndrome: Pre-clinical, clinical and therapeutic issues

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 6, 2013, Pages 993-996

  Martino, Davide ^a,b   Laviola, Giovanni ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ARIPIPRAZOLE; BOTULINUM TOXIN; DOPAMINE; NEUROLEPTIC AGENT; PLACEBO;

BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; CHILDHOOD DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; EXPERIMENTAL MODEL; GILLES DE LA TOURETTE SYNDROME; HUMAN; MENTAL STRESS; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RISK FACTOR; STARTLE REFLEX; ANIMAL; DISEASE MODEL; DRUG SCREENING; TOURETTE SYNDROME;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; TOURETTE SYNDROME;

EID: 84891896591     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.02.018     Document Type: Editorial

References (2)

1. Cavanna A.E., Servo S., Monaco F., Robertson M.M. The behavioural spectrum of Gilles de la Tourette syndrome. J. Neuropsychiatry Clin. Neurosci. 2009, 21:13-23.
2. Robertson M.M., Eapen V., Cavanna A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J. Psychosom. Res. 2009, 67:475-483.